Africa

How Africa could soon start making its own medicines

A medical worker gives a dose of AstraZeneca's coronavirus disease (COVID-19) vaccine to a man, at the Ruaraka Uhai Neema Hospital in Nairobi, Kenya, April 8, 2021.

Supply chain disruptions from COVID-19 caused supplies to drop critically low. Image: REUTERS/Baz Ratner - RC2NRM9O4Q0V

Alison Buckholtz
Writer, World Bank Group
Share:
Our Impact
The Big Picture
Explore and monitor how Africa is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Africa

Have you read?
Frannie Léautier, CEO of SouthBridge Investments
Zeynep Kantur, Principal Investment Officer for health projects at IFC
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
AfricaCOVID-19Health and HealthcareGlobal Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

2,000 white rhinos bred in captivity will be rewilded across Africa to protect the species’ future

Andrea Willige

September 26, 2023

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum